BIOGEN INC (IDP.DE) Fundamental Analysis & Valuation

FRA:IDP • US09062X1037

Current stock price

154.55 EUR
-2.9 (-1.84%)
Last:

This IDP.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. IDP.DE Profitability Analysis

1.1 Basic Checks

  • IDP had positive earnings in the past year.
  • In the past year IDP had a positive cash flow from operations.
  • In the past 5 years IDP has always been profitable.
  • IDP had a positive operating cash flow in each of the past 5 years.
IDP.DE Yearly Net Income VS EBIT VS OCF VS FCFIDP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • With a decent Return On Assets value of 4.39%, IDP is doing good in the industry, outperforming 78.75% of the companies in the same industry.
  • The Return On Equity of IDP (7.08%) is better than 80.00% of its industry peers.
  • With an excellent Return On Invested Capital value of 8.93%, IDP belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
  • IDP had an Average Return On Invested Capital over the past 3 years of 8.93%. This is below the industry average of 11.89%.
  • The 3 year average ROIC (8.93%) for IDP is below the current ROIC(8.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.39%
ROE 7.08%
ROIC 8.93%
ROA(3y)4.85%
ROA(5y)6.69%
ROE(3y)8.23%
ROE(5y)12.34%
ROIC(3y)8.93%
ROIC(5y)10.93%
IDP.DE Yearly ROA, ROE, ROICIDP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • The Profit Margin of IDP (13.07%) is better than 80.00% of its industry peers.
  • In the last couple of years the Profit Margin of IDP has declined.
  • IDP's Operating Margin of 27.94% is amongst the best of the industry. IDP outperforms 83.75% of its industry peers.
  • In the last couple of years the Operating Margin of IDP has declined.
  • The Gross Margin of IDP (75.69%) is better than 65.00% of its industry peers.
  • In the last couple of years the Gross Margin of IDP has declined.
Industry RankSector Rank
OM 27.94%
PM (TTM) 13.07%
GM 75.69%
OM growth 3Y-3.78%
OM growth 5Y-5.27%
PM growth 3Y-24.15%
PM growth 5Y-15.17%
GM growth 3Y-0.7%
GM growth 5Y-2.57%
IDP.DE Yearly Profit, Operating, Gross MarginsIDP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IDP.DE Health Analysis

2.1 Basic Checks

  • IDP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for IDP has been increased compared to 1 year ago.
  • IDP has less shares outstanding than it did 5 years ago.
  • IDP has a better debt/assets ratio than last year.
IDP.DE Yearly Shares OutstandingIDP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
IDP.DE Yearly Total Debt VS Total AssetsIDP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • IDP has an Altman-Z score of 3.25. This indicates that IDP is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of IDP (3.25) is better than 66.25% of its industry peers.
  • The Debt to FCF ratio of IDP is 3.11, which is a good value as it means it would take IDP, 3.11 years of fcf income to pay off all of its debts.
  • IDP's Debt to FCF ratio of 3.11 is amongst the best of the industry. IDP outperforms 86.25% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that IDP is not too dependend on debt financing.
  • The Debt to Equity ratio of IDP (0.34) is better than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.11
Altman-Z 3.25
ROIC/WACC1
WACC8.9%
IDP.DE Yearly LT Debt VS Equity VS FCFIDP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • IDP has a Current Ratio of 2.68. This indicates that IDP is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of IDP (2.68) is comparable to the rest of the industry.
  • A Quick Ratio of 2.03 indicates that IDP has no problem at all paying its short term obligations.
  • The Quick ratio of IDP (2.03) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 2.03
IDP.DE Yearly Current Assets VS Current LiabilitesIDP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. IDP.DE Growth Analysis

3.1 Past

  • IDP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.16%.
  • The earnings per share for IDP have been decreasing by -14.17% on average. This is quite bad
  • IDP shows a small growth in Revenue. In the last year, the Revenue has grown by 2.22%.
  • The Revenue has been decreasing by -5.96% on average over the past years.
EPS 1Y (TTM)-7.16%
EPS 3Y-6.07%
EPS 5Y-14.17%
EPS Q2Q%-42.15%
Revenue 1Y (TTM)2.22%
Revenue growth 3Y-0.93%
Revenue growth 5Y-5.96%
Sales Q2Q%-7.14%

3.2 Future

  • Based on estimates for the next years, IDP will show a small growth in Earnings Per Share. The EPS will grow by 3.53% on average per year.
  • IDP is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.48% yearly.
EPS Next Y5.16%
EPS Next 2Y4.3%
EPS Next 3Y4.87%
EPS Next 5Y3.53%
Revenue Next Year-3.94%
Revenue Next 2Y-2.41%
Revenue Next 3Y-1.25%
Revenue Next 5Y-0.48%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IDP.DE Yearly Revenue VS EstimatesIDP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
IDP.DE Yearly EPS VS EstimatesIDP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

7

4. IDP.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.65, the valuation of IDP can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of IDP indicates a rather cheap valuation: IDP is cheaper than 93.75% of the companies listed in the same industry.
  • IDP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.60.
  • IDP is valuated reasonably with a Price/Forward Earnings ratio of 11.08.
  • IDP's Price/Forward Earnings ratio is rather cheap when compared to the industry. IDP is cheaper than 96.25% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of IDP to the average of the S&P500 Index (22.84), we can say IDP is valued rather cheaply.
Industry RankSector Rank
PE 11.65
Fwd PE 11.08
IDP.DE Price Earnings VS Forward Price EarningsIDP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IDP is valued cheaply inside the industry as 92.50% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, IDP is valued cheaper than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.95
EV/EBITDA 7.85
IDP.DE Per share dataIDP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of IDP may justify a higher PE ratio.
PEG (NY)2.26
PEG (5Y)N/A
EPS Next 2Y4.3%
EPS Next 3Y4.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IDP.DE Dividend Analysis

5.1 Amount

  • IDP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IDP.DE Fundamentals: All Metrics, Ratios and Statistics

BIOGEN INC

FRA:IDP (4/2/2026, 7:00:00 PM)

154.55

-2.9 (-1.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-06
Earnings (Next)04-29
Inst Owners97.35%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap22.68B
Revenue(TTM)9.89B
Net Income(TTM)1.29B
Analysts73.02
Price Target177.03 (14.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.18%
Min EPS beat(2)20.87%
Max EPS beat(2)21.48%
EPS beat(4)4
Avg EPS beat(4)24.64%
Min EPS beat(4)17.28%
Max EPS beat(4)38.92%
EPS beat(8)8
Avg EPS beat(8)17.2%
EPS beat(12)12
Avg EPS beat(12)12.76%
EPS beat(16)15
Avg EPS beat(16)12.81%
Revenue beat(2)2
Avg Revenue beat(2)3.75%
Min Revenue beat(2)1.26%
Max Revenue beat(2)6.23%
Revenue beat(4)4
Avg Revenue beat(4)6.45%
Min Revenue beat(4)1.26%
Max Revenue beat(4)11.62%
Revenue beat(8)6
Avg Revenue beat(8)2.98%
Revenue beat(12)9
Avg Revenue beat(12)2.26%
Revenue beat(16)11
Avg Revenue beat(16)1.92%
PT rev (1m)0%
PT rev (3m)13.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.21%
EPS NY rev (1m)5.69%
EPS NY rev (3m)4.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.82%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)1.32%
Valuation
Industry RankSector Rank
PE 11.65
Fwd PE 11.08
P/S 2.64
P/FCF 12.95
P/OCF 11.86
P/B 1.43
P/tB 10.1
EV/EBITDA 7.85
EPS(TTM)13.27
EY8.59%
EPS(NY)13.95
Fwd EY9.03%
FCF(TTM)11.94
FCFY7.72%
OCF(TTM)13.03
OCFY8.43%
SpS58.48
BVpS107.94
TBVpS15.3
PEG (NY)2.26
PEG (5Y)N/A
Graham Number179.52
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 7.08%
ROCE 10.59%
ROIC 8.93%
ROICexc 10.46%
ROICexgc 35.29%
OM 27.94%
PM (TTM) 13.07%
GM 75.69%
FCFM 20.42%
ROA(3y)4.85%
ROA(5y)6.69%
ROE(3y)8.23%
ROE(5y)12.34%
ROIC(3y)8.93%
ROIC(5y)10.93%
ROICexc(3y)9.96%
ROICexc(5y)13.03%
ROICexgc(3y)38.5%
ROICexgc(5y)36.85%
ROCE(3y)10.59%
ROCE(5y)12.95%
ROICexgc growth 3Y4.85%
ROICexgc growth 5Y-4.35%
ROICexc growth 3Y-13.95%
ROICexc growth 5Y-14.37%
OM growth 3Y-3.78%
OM growth 5Y-5.27%
PM growth 3Y-24.15%
PM growth 5Y-15.17%
GM growth 3Y-0.7%
GM growth 5Y-2.57%
F-Score4
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.11
Debt/EBITDA 1.77
Cap/Depr 23.77%
Cap/Sales 1.87%
Interest Coverage 10.46
Cash Conversion 62.22%
Profit Quality 156.18%
Current Ratio 2.68
Quick Ratio 2.03
Altman-Z 3.25
F-Score4
WACC8.9%
ROIC/WACC1
Cap/Depr(3y)46.72%
Cap/Depr(5y)49.51%
Cap/Sales(3y)2.92%
Cap/Sales(5y)2.77%
Profit Quality(3y)138.91%
Profit Quality(5y)133.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.16%
EPS 3Y-6.07%
EPS 5Y-14.17%
EPS Q2Q%-42.15%
EPS Next Y5.16%
EPS Next 2Y4.3%
EPS Next 3Y4.87%
EPS Next 5Y3.53%
Revenue 1Y (TTM)2.22%
Revenue growth 3Y-0.93%
Revenue growth 5Y-5.96%
Sales Q2Q%-7.14%
Revenue Next Year-3.94%
Revenue Next 2Y-2.41%
Revenue Next 3Y-1.25%
Revenue Next 5Y-0.48%
EBIT growth 1Y8.4%
EBIT growth 3Y-4.68%
EBIT growth 5Y-10.91%
EBIT Next Year16.69%
EBIT Next 3Y5.17%
EBIT Next 5Y1.28%
FCF growth 1Y-19.74%
FCF growth 3Y20.95%
FCF growth 5Y-11.3%
OCF growth 1Y-23.33%
OCF growth 3Y16.78%
OCF growth 5Y-12.22%

BIOGEN INC / IDP.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BIOGEN INC (IDP.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to IDP.DE.


What is the valuation status for IDP stock?

ChartMill assigns a valuation rating of 7 / 10 to BIOGEN INC (IDP.DE). This can be considered as Undervalued.


How profitable is BIOGEN INC (IDP.DE) stock?

BIOGEN INC (IDP.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for IDP stock?

The Price/Earnings (PE) ratio for BIOGEN INC (IDP.DE) is 11.65 and the Price/Book (PB) ratio is 1.43.


What is the earnings growth outlook for BIOGEN INC?

The Earnings per Share (EPS) of BIOGEN INC (IDP.DE) is expected to grow by 5.16% in the next year.